Latest / Decera Clinical Education Oncology Podcast
Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer
In this episode, Karim Fizazi, MD, PhD, and Joaquin Mateo, MD, PhD, discuss the underlying rationale for using PARP inhibitors in combination with other therapies to treat men with prostate cancer including:
Possible synergy between PARP inhibitors and androgen receptor–directed therapy
Rationale for PARP inhibitors and immunotherapy combinations
Benefits and challenges of combining DNA damaging agents and PARP inhibitor
Presenters:
Karim Fizazi, MD, PhD
Full Professor
Cancer Medicine
Institut Gustave Roussey
Villejuif, France
Joaquin Mateo, MD, PhD
Attending Physician
Medical Oncology
Vall…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.